Acoustone 180 Ceiling Tile by United States Gypsum

Product Description

Acoustone 180 was an acoustical ceiling tile manufactured by United States Gypsum Company (USG), one of the largest producers of building products in North America throughout the twentieth century. The product was designed to provide sound absorption and noise reduction in commercial, institutional, and industrial interior environments. Ceiling tiles of this category were widely specified by architects and building contractors from mid-century onward, appearing in office buildings, schools, hospitals, government facilities, and industrial plants across the United States.

USG marketed the Acoustone line under its well-established brand identity, positioning these tiles as a functional and cost-effective solution for interior ceiling systems. The “180” designation referred to a specific product formulation within the broader Acoustone family. Like many building materials produced during the peak decades of asbestos use, Acoustone 180 tiles were manufactured during an era when asbestos mineral fibers were routinely incorporated into construction products to enhance fire resistance, durability, and structural integrity. USG produced a range of building products—including ceiling tiles, joint compounds, and related materials—that have subsequently been the subject of asbestos-related litigation.

The tiles were typically installed in suspended grid ceiling systems or adhered directly to substrate surfaces, making them a common feature of interior construction projects throughout the latter half of the twentieth century. As a result, Acoustone 180 ceiling tiles were encountered not only during original installation but also during building renovation, demolition, and routine maintenance work spanning multiple decades.

Asbestos Content

Litigation records document that plaintiffs have alleged Acoustone 180 ceiling tiles contained asbestos as a constituent material in their manufactured composition. Acoustical ceiling products of this type and era were commonly formulated with asbestos fibers—most frequently chrysotile (white asbestos)—blended into mineral fiber or cellulose substrates. Asbestos was valued in these applications for its fibrous binding properties, dimensional stability, and capacity to resist heat and flame spread, all characteristics that aligned with building code requirements and commercial performance standards of the time.

Plaintiffs in asbestos litigation have alleged that USG incorporated asbestos-containing materials into Acoustone products without providing adequate warnings to workers or end users regarding the health hazards associated with asbestos fiber release. The specific percentage of asbestos by weight in Acoustone 180 formulations has been a subject of examination in litigation proceedings, with documentation entered into court records through product identification discovery, historical material safety data, and expert analysis of surviving tile samples.

It is established in the broader scientific and regulatory record—including findings under the Asbestos Hazard Emergency Response Act (AHERA)—that asbestos-containing ceiling tiles can release respirable fibers when cut, drilled, broken, sanded, or otherwise disturbed during installation, maintenance, or demolition activities.

How Workers Were Exposed

Industrial workers and construction trades personnel represent the primary population documented in litigation records as having been exposed to asbestos fibers associated with Acoustone 180 ceiling tiles. Exposure pathways were varied and often cumulative, reflecting the multiple phases of a building material’s life cycle.

Installation workers who cut, scored, and fitted ceiling tiles to size were positioned directly in the path of airborne dust generated during those operations. Dry cutting with hand saws or utility knives, and the use of power tools for trimming, could release respirable asbestos fibers into the breathing zone without adequate engineering controls or respiratory protection in place during the decades when such protective measures were not yet mandated or understood.

Maintenance and renovation workers, including pipefitters, electricians, HVAC technicians, and general maintenance personnel, routinely disturbed existing ceiling tile installations to access overhead utilities. Removing, repositioning, or breaking tiles to reach pipes, conduit, or ductwork above suspended ceilings created repeated short-duration exposures that litigation records document as a significant pathway for cumulative asbestos inhalation.

Demolition workers engaged in building teardowns or interior gut renovations encountered Acoustone 180 tiles in bulk quantities. Demolition activities—absent proper asbestos abatement protocols—were among the highest-exposure scenarios documented in occupational health literature and litigation records, as large surface areas of tile were broken simultaneously in poorly ventilated conditions.

General industrial workers employed in facilities where Acoustone 180 tiles had been installed overhead could experience bystander exposure when tiles were disturbed by others working in the same space, or when aging and deteriorating tiles shed fibers over time.

Plaintiffs have alleged that United States Gypsum was aware, or should have been aware, of the hazards posed by asbestos-containing building products and that the company failed to provide adequate warnings on product packaging, in installation instructions, or through sales and distribution channels. This failure, plaintiffs alleged, deprived workers and building occupants of the information necessary to take protective measures.

Documented Trust Fund / Legal Options

Acoustone 180 ceiling tile claims fall under Tier 2 — Litigated status. There is no dedicated USG asbestos bankruptcy trust fund currently administering claims for this specific product, as United States Gypsum has addressed asbestos liabilities through litigation and related legal mechanisms rather than a standalone Section 524(g) bankruptcy trust of the type established by other asbestos manufacturers.

Litigation records document that claims involving USG asbestos-containing products, including ceiling tiles sold under the Acoustone brand, have been pursued in state and federal civil courts. Plaintiffs alleging injuries from Acoustone 180 exposure have brought claims sounding in product liability, negligence, failure to warn, and, in some cases, fraudulent concealment of known hazards.

Individuals who believe they were exposed to Acoustone 180 ceiling tiles and have received a diagnosis of an asbestos-related disease should consider the following steps:

  • Consult a qualified asbestos attorney experienced in product identification and occupational exposure documentation. Establishing the specific product and manufacturer is a critical threshold requirement in litigation.
  • Document work history with as much specificity as possible, including employer names, job sites, approximate dates, and the nature of tasks performed near or with ceiling tile materials.
  • Obtain medical records confirming diagnosis of an asbestos-related condition such as mesothelioma, asbestosis, lung cancer, or pleural disease from a physician experienced in occupational lung disease.
  • Investigate additional defendants, as asbestos exposure claims frequently involve multiple products and multiple manufacturers encountered across a worker’s career. Other trust funds or litigation targets may be available in addition to any claim involving USG products.

Statutes of limitations vary by state and typically begin running from the date of diagnosis or discovery of disease. Timely legal consultation is essential to preserve all available remedies.

This article is provided for informational and product documentation purposes only and does not constitute legal advice.